2015
DOI: 10.1016/j.bbrc.2015.05.001
|View full text |Cite
|
Sign up to set email alerts
|

TGF-β induced miR-132 enhances the activation of TGF-β signaling through inhibiting SMAD7 expression in glioma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 22 publications
0
19
0
1
Order By: Relevance
“…Strikingly, Smad7 can block TGF-β signaling through various means[80-82], such as binding TGFβRI to inhibit the interaction-dependent activation of Smad2, collaborating with other effectors to induce TGFβRI degradation, and regulating the Wnt/β-catenin pathway to influence TGF-β-induced apoptosis[83]. Similarly, targeting of Smad7 enhances TGF-β pathway activation[84]. …”
Section: Novel Therapeutic Targets In Liver Fibrosismentioning
confidence: 99%
“…Strikingly, Smad7 can block TGF-β signaling through various means[80-82], such as binding TGFβRI to inhibit the interaction-dependent activation of Smad2, collaborating with other effectors to induce TGFβRI degradation, and regulating the Wnt/β-catenin pathway to influence TGF-β-induced apoptosis[83]. Similarly, targeting of Smad7 enhances TGF-β pathway activation[84]. …”
Section: Novel Therapeutic Targets In Liver Fibrosismentioning
confidence: 99%
“…TGF-β may upregulate the miR-132 expression level in dose-and time-dependent manners, and may further enhance the activation of TGF-β signaling by inhibiting SMAD7 expression in glioma cells (18). TGF-β additionally serves important regulatory functions in CC, as for example, the oncoproteins of HPVs may stimulate TGF-β1 expression in CC cells, which in turn suppresses the host immune surveillance towards CC, and triggers the EMT process, migration and metastasis of CC cells (30)(31)(32)(33).…”
Section: Discussionmentioning
confidence: 99%
“…Transforming growth factor (TGF)-β is a multifunctional cytokine and may induce numerous important signaling pathways in several types of cancer cells (15,16). Furthermore, TGF-β may regulate the expression of TSLP in the intervertebral disc tissue (17) and regulate the expression of miR-132 in glioma cells (18). However, it remains unknown whether TSLP regulates the biological behaviors by modulating the expression of miR-132 in CC.…”
Section: Introductionmentioning
confidence: 99%
“…Functionally, miR-132 promoted lymphangiogenic response, whereas miR-132 inhibition suppressed LECs proliferation, migration and tube formation. TGF-β plays an important role in lymphangiogenesis [33,34], and the correlation of miR-132 with TGF-β/Smad signaling was revealed in several cancer [35,37]. We thus investigated whether miR-132 promoted lymphangiogenic response by regulating TGF-β/Smad signaling.…”
Section: Cellular Physiology and Biochemistrymentioning
confidence: 99%
“…Additionally, the correlation of miR-132 with TGF-β/Smad signaling was revealed in several cancer, including glioma [35], prostate cancer [36] and non-small cell lung cancer [37]. Therefore, we next investigated whether miR-132 promotes lymphangiogenic response by regulating TGF-β/Smad signaling.…”
Section: Exosomes From-adscs/vegf-c (Exosome-adscs/ Vegf-c) Promote Lmentioning
confidence: 99%